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Background
Radical treatment of cancer, is also in the ederly, the
gold standard of surgery. If the patient’s performance
status contraindicated radical surgery, palliative treat-
ment is the only possibility to improve survival and the
patient’s quality of life. We report our experience related
to the treatment of 250 esophageal-cardiac tumors.
Materials and methods
From 2000 to 2007 we treated 250 patients(mean age 72
aa) initially at surgical clinic of II medical school of
Naples university and then at Catanzaro medical school.
In our series (Table 1),there was a prevalence of pallia-
tive resection compared to other procedures.
Results
In our conviction we consider the excision of tumors
with total obstruction of esophageal lumen palliative,even
if the surgical procedure is apparently complete. Total
mortality(9%) and a slightly higher morbidity legitimize
this approach.We perform the reconstruction of the ali-
mentary tract continuity with the stomach in 144
patients. Only in 4 cases, where we used a left colon graft
did we report a higher mortality and morbidity. In
patients at high surgical risk: broncho-esophageal fistula
or diffuse metastasis, we perform palliative procedures.
The by-pass with left colon graft was used in 24 cases,
with high mortality and morbidity and poor mean survi-
val(9,7 months) ;at the moment, in such cases, we prefer
to use tubulized stomach at retrosternal place. Non
expandable wallstent has been applied with open surgical
procedure in 14 cases( mortality 35%;morbidity 50% ). In
19 patients in whom we applied a non expandable stent
by endoscopic technique (Nottingham set) we report no
mortality and low morbidity. Finally 40 patients were
treated with simple endoscopic dilatation( Malooney’s
metal probes ),with no mortality and mean survival
(6,3 months) just under that obtained with a palliative
by-pass.
Conclusions
The advent of expandable endoprosthesis, in recent
years, has changed our therapeutic approach in palliative
treatment of esophageal-cardiac cancer in the ederly.
By-pass procedures, in our experience, have gradually
declined in order to increase mortality and lower survi-
val of treated patients. We believe that by-pass proce-
dures for this digestive system tract exist due to the fact
that the use of the expandable wallstent is limited by
high costs, about 10 times higher than those of tradi-
tional implants.
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Table 1 Palliative treatment (250 patients)
Treatment Patients morbidity Mortality survival(*)
palliative resection 148 18 (12%) 13(9%) 21
By pass 29 8 (27%) 6 (20%) 6,5
Endoprosthesis (T) 14 7 (50%) 5 (35%) 3,1
Endoprosthesis (P) 19 1(5%) 0 6.5
Dilatazion 40 1 (2.5%) 0 6.3
Laser _ _
Radiotherapy _ _
* median survival in months
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